Result In the 13‐week study, 3D6‐L significantly reduced guanidium‐HCL‐soluble Aβx‐42 and Aβx‐40; ApoE levels showed a trend for reduction.
← all excerpts
Anti‐Amyloid Immunotherapy for AD: A Potential Link between ARIA and Complement
1
—
—
Result In the 13‐week study, 3D6‐L significantly reduced guanidium‐HCL‐soluble Aβx‐42 and Aβx‐40; ApoE levels showed a trend for reduction.